title: Comments on 'maintaining confidentiality of interim data to enhance trial integrity and credibility' by TR Fleming et al.
authors.forename: Edward L
authors.initials: EL
authors.lastname: Korn
authors.forename: Sally
authors.initials: S
authors.lastname: Hunsberger
authors.forename: Boris
authors.initials: B
authors.lastname: Freidlin
authors.forename: Malcolm A
authors.initials: MA
authors.lastname: Smith
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Abrams
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000627:therapeutic use; D026661:Clinical Trials Data Monitoring Committees; D003219:Confidentiality; D003627:Data Interpretation, Statistical; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D015203:Reproducibility of Results; D012107:Research Design
chemical_list: D019380:Anti-HIV Agents